Metrics Operations Pharmaceuticals Talent 
Harvard Business
OCTOBER 25, 2018
To analyze the superstar dynamics of firms, our metric was economic profit, a measure of a firm’s profit above and beyond opportunity cost. (To The top 10% of the firms we analyzed — the superstars by our metric — create 80% of all the economic value, meaning they account for 80% of economic profits.
Harvard Business
JUNE 22, 2016
For example, do you make and sell things, hire skilled employees and provide services, develop and new IP like software or pharmaceuticals, or build and manage digital networks, be they transactional, informational, or social? This will require reporting on new metrics. Finally, begin to track the progress of your network initiative.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business
OCTOBER 6, 2016
How talent management is changing. We mapped this data against dozens of financial and leadership metrics, clustering companies into four groups (ranging from low- to high-performing). And fifth, while these companies do have leadership “programs,” they are embedded in the business, and HR does not operate alone.
Harvard Business
OCTOBER 23, 2017
In a project for a pharmaceutical company, we were able to isolate the specific information sources that drove positive and negative sentiment toward the client’s brand. Organizations often seem obsessed by measuring fractional shifts in operational performance, capturing data on sales, inventory turns, and manufacturing efficiency.
Harvard Business
JUNE 23, 2016
A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. While a natural inclination, this group is (by design) representative of current operating units and functions, which often have a status quo to defend. paul Garbett for HBR.
Harvard Business
SEPTEMBER 30, 2016
Pay transparency thrives in organizations that abandon pay for performance; it struggles in environments where rewards are linked to subjective metrics. The other group consisted of production employees operating in a factory setting. Of course, rewarding these factors will demotivate and drive away the talent you would like to keep.
CaseInterview.com
FEBRUARY 7, 2019
Career progression is linear, with a focus on developing young talent. Its mature processes and dense infrastructure help ensure that talent is recognized quickly. However, the skill-building opportunities are widely praised, particularly for those with a deep interest in biotech and pharmaceuticals. women and 49.6%
Expert insights. Personalized for you.
44 
Let's personalize your content